Overview
Carl Blau is a primary care provider, practicing in Internal Medicine in Seattle, Washington.
His clinical expertise encompasses Acute Myeloid Leukemia (AML), Breast Cancer, Leukemia, and Triple-Negative Breast Cancer.
He is actively involved in clinical research, co-authoring 30 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
825 Eastlake Ave E, Seattle, WA 98109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Gme Office University Of Washington
David Dale is a primary care provider, practicing in Internal Medicine in Seattle, Washington. Dr. Dale is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Agranulocytosis, Chronic Familial Neutropenia, Cyclic Neutropenia, and Infantile Neutropenia. Dr. Dale is currently accepting new patients.
Fred Hutchinson Cancer Center
David Maloney is a primary care provider, practicing in Internal Medicine in Seattle, Washington. Dr. Maloney is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Chronic B-Cell Leukemia (CBCL). Dr. Maloney is currently accepting new patients.
Uw Medicine/Harborview Medical Center
Bruce Psaty is a primary care provider, practicing in Internal Medicine in Seattle, Washington. Dr. Psaty is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Atherosclerosis, Rhabdomyolysis, Coronary Heart Disease, Heart Failure, and Hormone Replacement Therapy (HRT). Dr. Psaty is currently accepting new patients.
Frequently Asked Questions about Dr. Carl A. Blau
How do I make an appointment with Dr. Carl A. Blau?
You can book an appointment with Dr. Carl A. Blau by calling their office at 855-557-0555. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Carl A. Blau a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Carl A. Blau is classified as an Experienced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Carl A. Blau specialize in?
While Dr. Carl A. Blau is a Internal Medicine, they have specific expertise in Acute Myeloid Leukemia (AML), Breast Cancer, and Leukemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Carl A. Blau participate in research or clinical trials?
Yes. Dr. Carl A. Blau has published 30 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Carl A. Blau's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Blau isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Breast CancerDr. Blau isExperienced. Learn about Breast Cancer.
- LeukemiaDr. Blau isExperienced. Learn about Leukemia.
- Triple-Negative Breast CancerDr. Blau isExperienced. Learn about Triple-Negative Breast Cancer.